Eleven Biotherapeutics, Inc. (EBIO) - NASDAQ

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Company Description
Eleven Biotherapeutics, Inc. is a preclinical stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it apply to the discovery and development of protein therapeutics to treat diseases of the eye. Its therapeutic approach is based on the role of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States